glp-1 and eating disorder obesity drugs disorders are not well understood yet : NPR Eating disorder groups are sounding
Description
Larger and more diverse patient cohorts are needed, lower dosages of semaglutide have to be tested, and follow-ups need to be conducted beyond 26 weeks.
Headlines often describe them as miracle drugs, pointing to dramatic weight loss and improvements in blood sugar, heart health and liver disease
doi: 10.1016/0167-0115(81)90007-0 271 BaldisseraFGAHolstJJKnuhtsenSHilstedLNielsenOV
However, understanding the pharmacodynamics of these medications is crucial
This not only helps with satiety but also supports stable blood sugar levels and good gut health
